BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND H3F3B, H3_3A, 3021, ENSG00000132475, P84243, H3_3B, MGC87783, MGC87782, H3F3
13 results:

  • 1. Knockout tales: the versatile roles of histone H3.3 in development and disease.
    Klein RH; Knoepfler PS
    Epigenetics Chromatin; 2023 Oct; 16(1):38. PubMed ID: 37814296
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors.
    Cao GZ; Ma LY; Zhang ZH; Wang XL; Hua JH; Zhang JH; Lv Y; Zhang SB; Ou J; Lin WC
    Acta Pharmacol Sin; 2023 Apr; 44(4):841-852. PubMed ID: 36253561
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Chondroblastoma-like osteosarcoma: a clinicopathological and molecular study of a rare osteosarcoma variant.
    Gaeta R; Righi A; Gambarotti M; Aretini P; Lessi F; Mazzanti CM; Mancini I; Pinzani P; Belgio B; Sbaraglia M; Tos APD; Franchi A
    Histopathology; 2022 Sep; 81(3):389-401. PubMed ID: 35791778
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Drivers underpinning the malignant transformation of giant cell tumour of bone.
    Fittall MW; Lyskjaer I; Ellery P; Lombard P; Ijaz J; Strobl AC; Oukrif D; Tarabichi M; Sill M; Koelsche C; Mechtersheimer G; Demeulemeester J; Tirabosco R; Amary F; Campbell PJ; Pfister SM; Jones DT; Pillay N; Van Loo P; Behjati S; Flanagan AM
    J Pathol; 2020 Dec; 252(4):433-440. PubMed ID: 32866294
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1/CYP1B1 inhibitors: Identification of quinazolinones as CYP1A1/CYP1B1 inhibitors that efficiently reverse B[a]P toxicity and cisplatin resistance.
    Sonawane VR; Siddique MUM; Gatchie L; Williams IS; Bharate SB; Jayaprakash V; Sinha BN; Chaudhuri B
    Eur J Pharm Sci; 2019 Apr; 131():177-194. PubMed ID: 30776468
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical research on therapeutic effect of combined application of lobaplatin and irinotecan in treating recurrant small cell lung cancer.
    Zhang H; Zhang Y; Wang C; Fang S; Xu B; Wang C; Wu J; Liu D
    Pak J Pharm Sci; 2018 Sep; 31(5(Special)):2295-2298. PubMed ID: 30463828
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
    Righi A; Mancini I; Gambarotti M; Picci P; Gamberi G; Marraccini C; Dei Tos AP; Simi L; Pinzani P; Franchi A
    Hum Pathol; 2017 Oct; 68():128-135. PubMed ID: 28899740
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gefitinib plus Fuzheng Kang'ai Formula () in Patients with Advanced Non-Small Cell lung cancer with Epidermal Growth Factor Receptor Mutation: A Randomized Controlled Trial.
    Yang XB; Chai XS; Wu WY; Long SQ; Deng H; Pan ZQ; He WF; Zhou YS; Liao GY; Xiao SJ
    Chin J Integr Med; 2018 Oct; 24(10):734-740. PubMed ID: 28795387
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Histologic Spectrum of Giant Cell Tumor (GCT) of Bone in Patients 18 Years of Age and Below: A Study of 63 Patients.
    Al-Ibraheemi A; Inwards CY; Zreik RT; Wenger DE; Jenkins SM; Carter JM; Boland JM; Rose PS; Jin L; Oliveira AM; Fritchie KJ
    Am J Surg Pathol; 2016 Dec; 40(12):1702-1712. PubMed ID: 27526293
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Interaction of polymorphisms of monocyte chemoattractant protein-1 receptor CCR2 gene 190A/G, nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene C242T and cigarette smoking increases the risk of nonalcoholic fatty liver disease].
    Zhang C; Guo L
    Wei Sheng Yan Jiu; 2015 Sep; 44(5):730-7. PubMed ID: 26591766
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Biological Therapeutics Research and Development--GTCbio's Fifth Annual Conference. October 20-22, 2010, San Francisco, CA, USA.
    Garren H
    IDrugs; 2010 Dec; 13(12):840-2. PubMed ID: 21154139
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin.
    Tang N; Du G; Wang N; Liu C; Hang H; Liang W
    J Natl Cancer Inst; 2007 Jul; 99(13):1004-15. PubMed ID: 17596572
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.